Zovirax
5 customer reviewsZovirax is an antiviral medicine containing acyclovir. It is for people being treated for herpes virus infections such as cold sores, genital herpes, or shingles. It works by inhibiting viral DNA replication to reduce viral activity during outbreaks.
What is it?
Zovirax is an antiviral medicine built around acyclovir, used for herpes virus infections where suppressing viral activity early can shorten symptoms and reduce new lesion formation. Cold sores are a type of viral skin infection, and the classic “fever blister” on the lip is usually herpes labialis caused by herpes simplex virus type 1 (HSV-1). Genital herpes is more often linked to HSV‑2, yet both HSV‑1 and HSV‑2 can affect either location.
Zovirax does not remove herpes from the body permanently. It reduces viral replication during an outbreak, so your immune system can regain control faster.
Two practical points matter in real life: treatment works best when started early, and hydration matters more than people expect with oral acyclovir therapy.
Composition
Active ingredient: acyclovir (tablet strength varies by prescription, commonly 200 mg, 400 mg, or 800 mg per tablet). Excipients may include tablet fillers and binders such as cellulose derivatives, starches, and magnesium stearate; exact composition depends on the specific tablet strength and manufacturer batch.
How to use?
Used for treatment and suppression of herpes virus infections: herpes labialis (cold sores), genital herpes, and varicella-zoster infections such as shingles. It may also be prescribed for chickenpox in selected patients and for prevention of recurrent outbreaks in people with frequent recurrences or reduced immunity. Use only as prescribed and start treatment as early as possible after symptom onset.
How does it work?
- Route: oral (tablets)
- Herpes labialis (cold sores): 400 mg 5 times/day (about every 4 hours while awake), with or without food, for 5 days.
- Genital herpes, initial episode: 200 mg 5 times/day (about every 4 hours while awake), with or without food, for 10 days.
- Genital herpes, recurrent episode: 200 mg 5 times/day for 5 days, or 400 mg 3 times/day for 5 days; with or without food.
- Suppressive therapy (recurrent genital herpes): 400 mg 2 times/day, with or without food; duration commonly 6–12 months with periodic reassessment.
- Shingles (herpes zoster): 800 mg 5 times/day (about every 4 hours while awake), with or without food, for 7–10 days.
- Chickenpox (varicella): 800 mg 4 times/day, with or without food, for 5 days (use depends on age and clinical need).
- Timing notes: space doses evenly during waking hours; drink water with doses to support hydration.
Indications
Zovirax is used for herpes simplex virus infections such as cold sores (herpes labialis) and genital herpes, and it is also used for herpes zoster (shingles), which is caused by varicella-zoster virus (a different herpes virus family member). Herpes zoster is a type of condition where viral reactivation causes a painful, often one-sided blistering rash, and early antiviral treatment can reduce new lesion formation and shorten viral shedding in many patients [2].
A key difference is topical versus systemic need:
- Cold sores are often localized and may be treated topically in mild cases.
- Genital herpes is typically treated with oral antivirals, since the infection involves mucosal tissue and deeper nerve reactivation.
- Herpes zoster usually requires oral antiviral therapy, started early, because the virus affects nerve pathways and can drive significant pain.
Zovirax can reduce symptoms, but it does not eradicate herpes from the body. Recurrence prevention may require episodic treatment (at outbreak start) or suppressive therapy in people with frequent recurrences.
Comparison
Both options target cold sores, yet they work in different ways. Zovirax (acyclovir) is a topical antiviral agent in cream form and an antiviral tablet for systemic therapy; Abreva (docosanol) is a topical, non‑prescription cold sore treatment that interferes with viral entry/fusion at the skin cell membrane rather than blocking viral DNA replication.
The practical takeaway: for frequent or severe herpes outbreaks, systemic antiviral therapy is often chosen by clinicians, while topical approaches are more suited to mild, localized cold sores and very early use.
| Feature | Zovirax | Abreva |
|---|---|---|
| Active ingredient | Acyclovir | Docosanol |
| How it works | Inhibits viral replication | Reduces viral entry into cells |
Contraindications
- Hypersensitivity to acyclovir (or closely related antivirals like valacyclovir)
- Severe kidney disease unless the dose has been adjusted for renal function
- Breastfeeding when advised to avoid systemic acyclovir exposure
Not recommended for
Do not use Zovirax tablets if you are allergic to acyclovir or similar antivirals, or if you have severe kidney problems unless a clinician has adjusted your dose. Avoid it if you are breastfeeding and have been told not to use systemic acyclovir. Do not buy tablets for a child under 3 years old unless a clinician has specifically advised this form.
Side effects
Side effects depend on whether acyclovir is used topically or orally. With tablets, effects are systemic, so you can see more whole‑body reactions than with a topical antiviral agent.
Common or expected effects reported with oral acyclovir include:
- Headache
- Nausea or stomach upset
- Diarrhoea
- Dizziness
- Tiredness
Less common but clinically important risks include kidney-related side effects, especially if you are dehydrated or have pre‑existing kidney disease. Rarely, neurotoxicity symptoms (confusion, agitation, tremor) can occur, mainly in older adults or in renal impairment where drug levels rise.
Acyclovir can be hard on kidneys when fluid intake is low.
Common mistakes
People usually don’t struggle with the idea of antivirals; they struggle with timing and habits.
- Starting late: waiting until lesions crust over before beginning oral therapy.
- Under-hydrating: taking tablets with little fluid, raising kidney stress in susceptible patients.
- Dose clustering: taking several missed doses close together, which increases side effects without improving control.
- Assuming “no new sores” means non-contagious: viral shedding can still occur around outbreaks.
- Using oral tablets as a substitute for trigger control: sun exposure and lip trauma can still set off recurrent cold sore outbreaks.
Doctor opinions
In day-to-day prescribing, doctors tend to use Zovirax tablets when the outbreak pattern is frequent, lesions are extensive, or the infection is genital herpes where systemic therapy is standard. In clinic follow-ups, one consistent observation is that patients who start treatment at the first prodrome (tingling, burning, nerve pain) report shorter and less intense episodes than those who wait for clear blisters.
I also see a predictable trade-off: acyclovir works, but the dosing schedule can be demanding. People who miss doses often assume the medicine “failed,” when the real issue is irregular spacing and late initiation.
Another pattern: for herpes zoster, clinicians push for early initiation because later treatment may still help, yet the benefit on new lesion formation and viral shedding is strongest early in the course.
Frequently asked questions
Zovirax begins acting against herpes viruses soon after absorption, yet symptom relief is not immediate. Many people notice reduced formation of new blisters within the first 24–48 hours when treatment starts early in the outbreak. EMA clinical summaries describe the benefit as greatest when antivirals are started promptly in the course of infection [5].
No. Zovirax suppresses viral replication during active infection, but herpes viruses remain latent in nerve cells and can reactivate later. WHO patient-facing guidance on herpes infections explains that antivirals control outbreaks and reduce symptoms rather than eradicate the virus from the body.
Take the missed dose when you remember if it is still reasonably spaced from the next dose. If it is close to the next scheduled dose, skip the missed one and return to the regular schedule; doubling doses increases side effects without improving viral control. EMA safety information for acyclovir highlights dose adjustment and careful use in renal impairment, which is relevant when people “catch up” incorrectly.
It can reduce viral replication during outbreaks, which can reduce viral shedding, yet it does not eliminate transmission risk. Avoiding direct contact with active lesions remains the most reliable preventive step, and barrier protection reduces risk for genital herpes. WHO guidance on HSV transmission stresses that asymptomatic shedding can occur, so prevention is not only about visible sores.
Acyclovir is cleared by the kidneys, so kidney problems often mean a lower dose or longer intervals between doses. The clinical risk is drug accumulation, which can raise the chance of kidney injury and, rarely, nervous system side effects. MOHAP-aligned practice typically involves renal dosing based on estimated creatinine clearance, with extra attention to hydration.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Zovirax — Comparison with alternatives
Zovirax Current Best price Best rated
Tivicay
Tamiflu
Famvir
Valtrex
Available Zovirax Products and Strengths
Zovirax is used across herpes infections in different dosage forms depending on where the virus is active and how severe the episode is. The most common forms discussed clinically include Zovirax tablets for systemic treatment and acyclovir 5% cream for localized cold sores.
On this page, Zovirax is supplied as pills (tablets) in strengths that may include 200 mg, 400 mg, and 800 mg, as selected on the product card above. The strength matters because dosing is tailored to the infection type (for example, initial genital herpes versus recurrent episodes versus herpes zoster), kidney function, and immune status.
Zovirax is not a “one-dose” antiviral. Dosing schedules can be frequent, and that influences real-world results.
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Acyclovir: Summary of Product Characteristics (SmPC). ↑
- World Health Organization (WHO) (2026). Herpes simplex virus: Fact sheet and patient guidance. ↑
- MOHAP (Ministry of Health and Prevention) (2026). Antimicrobial and antiviral stewardship guidance for outpatient care. ↑
- World Health Organization (WHO) (2026). Guidance on medicine use in pregnancy and breastfeeding. ↑
- European Medicines Agency (EMA) (2026). Herpes antivirals: clinical efficacy and safety overview. ↑